EPZM
Epizyme, Inc
EPZM
EPZM
Delisted
EPZM was delisted on the 11th of August, 2022.
136 hedge funds and large institutions have $2.25B invested in Epizyme, Inc in 2019 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 39 increasing their positions, 39 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
136
Holders Change
+21
Holders Change %
+18.26%
% of All Funds
2.69%
Holding in Top 10
10
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+100%
% of All Funds
0.2%
New
40
Increased
39
Reduced
39
Closed
18
Calls
$83.6M
Puts
$7.16M
Net Calls
+$76.4M
Net Calls Change
+$73.9M
Top Buyers
1 |
RM
RP Management
New York
|
+$164M |
2 |
Primecap Management
Pasadena,
California
|
+$53.7M |
3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$33.8M |
4 |
AG
Artal Group
Luxembourg
|
+$18.5M |
5 |
Janus Henderson Group
London,
United Kingdom
|
+$13.9M |
Top Sellers
1 |
Millennium Management
New York
|
-$28.6M |
2 |
FCMI
Foresite Capital Management II
Larkspur,
California
|
-$22.1M |
3 |
Citadel Advisors
Miami,
Florida
|
-$13.6M |
4 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
-$10.6M |
5 |
State Street
Boston,
Massachusetts
|
-$9.65M |